Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2020 / Article

Research Article | Open Access

Volume 2020 |Article ID 6423783 | https://doi.org/10.1155/2020/6423783

Izabela Sadowska-Bartosz, Grzegorz Bartosz, "Effect of Antioxidants on the Fibroblast Replicative Lifespan In Vitro", Oxidative Medicine and Cellular Longevity, vol. 2020, Article ID 6423783, 15 pages, 2020. https://doi.org/10.1155/2020/6423783

Effect of Antioxidants on the Fibroblast Replicative Lifespan In Vitro

Academic Editor: Silvana Hrelia
Received12 Jul 2020
Revised04 Sep 2020
Accepted12 Sep 2020
Published23 Sep 2020

Abstract

Replicative senescence is an unalterable growth arrest of primary cells in the culture system. It has been reported that aging in vivo is related to the limited replicative capacity that normal somatic cells show in vitro. If oxidative damage contributes to the lifespan limitation, antioxidants are expected to extend the replicative lifespan of fibroblasts. This article critically reviews the results of experiments devoted to this problem performed within the last decades under conditions of in vitro culture. The results of studied are heterogeneous, some papers showing no effects of antioxidants; most finding limited enhancement of reproductive capacity of fibroblasts, some reporting a significant extension of replicative lifespan (RLS). Both natural and synthetic antioxidants were found to extend the RLS of fibroblasts, either by a direct antioxidant effect or, indirectly, by activation of signaling pathways and activation of proteasomes or hormetic effects. Most significant prolongation of RLS was reported so far for nicotinamide, N-hydroxylamines, carnosine and Methylene Blue. These results may be of importance for the design of skin-protecting cosmetics.

1. Introduction

The skin is the largest and the most visible organ of the human body. Aged skin is biologically characterized by the flattening of the dermal-epidermal junction and a general atrophy of the extracellular matrix (ECM) with disorganized and reduced collagen and elastin. Fibroblasts are one the most important cellular components of the skin derma. In the skin, fibroblasts are responsible for the whole range of various functions. They include both homeostasis of the dermal ECM and maintenance of the physiological condition of other skin layers. The former is carried out by remodeling and renewing the ECM through degradation of used up dermal components and synthesis of new ones, predominantly collagen and elastin. During aging, skin fibroblasts undergo substantial changes in their morphology, functional activity, and proliferative potential. The number of dermal fibroblasts decreases with aging; this phenomenon, along with impairment of functional capacities of the remaining cells results in decreased ability to synthesize active soluble factors and to maintain proteostasis of components of the ECM. The skin thinning, the loss of skin flexibility and elasticity, and wrinkle formation, hallmarks of skin aging, are natural consequences of such a decline [1].

Fibroblasts have been the first and most broad cells cultured in vitro. Initially, it was believed that fibroblasts are immortal in in vitro culture [2], but later on, Hayflick demonstrated that their rRLS is limited. Hayflick and Moorhead found that human fibroblasts grown in vitro eventually reach a senescent condition (Phase III) after a long period of normal growth (Phase II) from the establishment of the primary culture (Phase I). At stage III, cells are arrested at the G1 phase of the cell cycle and express a specific morphological and biochemical phenotype [3, 4]. Telomere shortening is believed to be an intrinsic mechanism that limits the cellular doubling capacity, at least in human cells [5], although telomerase-independent mechanisms can contribute [68]. In human somatic cells, telomeres are eroded by almost 30–200 bp by each DNA replication [9]. When foreskin fibroblasts were transfected with vectors encoding the human telomerase catalytic subunit, in contrast to control clones, which showed telomere shortening and senescence, the telomerase-expressing clones had elongated telomeres, divided vigorously, and showed reduced staining for acidic β-galactosidase. The telomerase-expressing clones had a normal karyotype and exceeded their normal lifespan by at least 20 doublings [10].

Telomere shortening and/or telomere attrition is probably recognized as DNA damage, inducing a DNA damage checkpoint response [11]. Without being repaired, shortened telomeres cause continuous activation of the p53-growth inhibitory pathway and therefore drive cells into a state of irreversible growth arrest. Increased histone acetylation evoked by histone deacetylase (HDAC) inhibitors has been reported to induce senescence-related phenotypes in cultured human cells [8]. An increase in histone acetylation may be due to decreased nicotinamide adenine dinucleotide- NAD+-dependent HDAC (N-HDAC) activity in aging fibroblasts [12]. Interestingly, the protein Sir2, a gene silencer and positive longevity regulator in yeast, has been found to be N-HDAC [13].

A fundamental question is if all fibroblasts age replicatively at the same rate or if there is an inherent asymmetry in the replicative potential of dividing cells. While a tacit assumption of most of the studies is that the replicative potential is evenly distributed between daughter cells, there are some hints that it may not be the case. The variability of the results of in vitro longevity studies can be explained on the basis of the commitment theory of cellular aging. This theory implies that stem-like cells that are not committed to senescence are present in early passage fibroblast populations, but they give rise to committed cells with finite lifespan. During subsequent subcultivations, the uncommitted cells are diluted stochastically and populations containing less or no uncommitted cells have shorter RLS. According to this theory, final cell populations may be single cell clones [1416].

To our knowledge, no published review has assembled research devoted to effect of antioxidants on the fibroblast RLS in vitro. This study is aimed at summarizing the available data on this subject.

Morphological changes accompanying replicative aging of fibroblasts concern a failure to line up and appearance of irregularities of size and shape including increase in cell size, enlargement and flattening of the cell soma, increase of the nuclear volume [17], accumulation of granular material in the cytoplasm and cell debris in the medium [3, 4], chromatin decondensation [18], development of aneuploidy [4] and polyploidy [19], loss of response to growth factors, decreased activity of cell-cycle-dependent enzymes [20], reduced saturation density, and increased level of DNA damage, including oxidative damage and strand breaks [21, 22]. Acidic (senescence-associated) β-galactosidase (staining for activity at pH 6.0; SA-β-gal) is increased [23] and is commonly used as a marker of fibroblast senescence.

Human fibroblasts arrest in the G1 phase of the cell cycle upon entering the senescent state [24]. G1 arrest of senescent fibroblasts is irreversible, and the cells do not respond to mitogenic signaling anymore. The level of reactive oxygen species (ROS) was reported to increase significantly in senescent (55 population doubling; PD) vs. young (18 PD) fibroblasts as estimated with 2,7-dichlorofluorescin diacetate (DCFDA) [25]. Using the same fluorogenic probe, Kang et al. found an approximately eightfold increase in the ROS level between cells at PD38 and PD83 [26]. This increase in the ROS level was not accompanied by any major changes in the Raf/MEK/ERK pathway with aging but was attributed to a constitutive activation of Jun kinase in senescent fibroblasts [25].

The expression of a number of genes is altered during fibroblast aging in vitro. Many of them, including p16, p21, EF1a, procollagen a1 (III), and fibronectin, exhibit a dramatic change in expression at the terminal phase of cell aging [2729]. The gene for PI3K IIb (a subtype of the PI3K family lipid/protein kinases) is upregulated by aging and downregulated by growth stimulation [12]. The accumulation of rhodamine 123 increases with increasing population PD, especially close to the end of RLS. The activity of aconitase, a FeS enzyme sensitive to oxidative stress, decreases [30]. Protein carbonyl content increases in senescent fibroblasts [31], although one study reported a decrease in this content [22].

3. The Effect of Antioxidants on the Replicative Lifespan of Fibroblasts

A hypoxic atmosphere was found to increase the RLS of fibroblasts in vitro. The replicative lifespan of IMR-90 cells cultured under 3% O2 was 142% and 157% (in two independent experiments) of that under 20% [32]. On this basis, it was expected that antioxidants would exert a similar effect.

One of the first papers concerning the effect of antioxidants on the fibroblast RLS reported a considerable prolongation of RLS by vitamin E (DL-α-tocopherol): 10 μg/ml and 100 μg/ml vitamin E increased RLS of WI-38 fibroblasts from 65 to 109 and 115 PD, respectively. The authors ascribed this effect to the restoration of vitamin E level typical of blood plasma (cell culture medium containing 10% fetal calf serum has about 10% of normal vitamin E level of blood plasma/serum). Removal of vitamin E after 73 PD did not attenuate the RLS prolongation [33]. However, the same authors were not able to reproduce this effect in subsequent experiments involving 19 subcultivations. In one set of experiments, control cells attained PD, while cells treated with 10 μg/ml vitamin E reached PD. In another set, the number of PD was and for control cells and cells supplemented with 50 μg/ml vitamin E, respectively. In experiments involving addition of 100 μg/ml vitamin E, the PD values were for control cells and for vitamin E-treated cells. The authors link this difference to the use of different batches of serum [34].

Another main physiological antioxidant vitamin, vitamin C (ascorbic acid), was found to dose-dependently extend RLS of human embryonic fibroblasts, by 2, 6, and 11 PD at 2, 20, and 200 μM ascorbic acid, respectively, when present from 40th PD. Ascorbic acid decreased also SA-β-gal staining and ROS level estimated with DCFDA and dihydrorhodamine 123, increased the activity of aconitase, and decreased the levels of p53, phospho-p53 (phosphorylated at Ser15), and p21 proteins and formation of apurinic/apyrimidinic sites and relieved senescence-related G1 arrest [35].

Ascorbic acid phosphoric ester, phosphorylated at the 2,3-enediol moiety of ascorbic acid, is a stable form of ascorbic acid providing a continuous effect with low cytotoxicity compared with ascorbic acid [36]. Ascorbic acid phosphate (200 μM) increased RLS of two lines of normal fibroblasts and a fibroblast line derived from a Werner syndrome patient by 3.5-8.5 PD and decreased the rate of telomere shortening. Treatment with ascorbic acid phosphate reduced the level of ROS detected with DCFDA in cells grown under 20% oxygen although it did not affect the ROS level in cells grown under 2% oxygen [37].

Resveratrol (3,5,4-trihydroxystilbene), a polyphenol found in grape skin and thus in wine, preventing age-related diseases in rodents and extending lifespan in several species, has been suggested to be a calorie restriction mimic although this view has been questioned [38]. This compound has been reported to activate sirtuins (e.g., human SIRT1) via an indirect mechanism [39]. Nevertheless, resveratrol was found to cause cell cycle arrest and even apoptosis at higher doses. For example, it was shown that 6.25–12.5 μM resveratrol blocked cell cycle, while 25 μM resveratrol caused apoptosis in vascular smooth muscle cells [40]. In cancer cells, resveratrol caused irreversible cell cycle arrest and appearance of senescent morphology [41]. The physiological level of resveratrol in human blood can reach a concentration of approximately 2 μM [42, 43]. Resveratrol concentrations higher than 10 μM have a cytostatic effect [44]. Resveratrol was reported to be unstable in cell culture medium. In Basal Modified Eagle’s Medium (BMEM), 96% of resveratrol was degraded and approximately 90 μM H2O2 was generated, when 200 μM resveratrol was incubated in BMEM at 37°C for 24 h. It was noticed that the degradation of resveratrol can be avoided by withdrawing sodium bicarbonate from the medium [45]. In another study, however, resveratrol was found to be quite stable in a cell culture medium, ca 75% of the initial concentration remaining after 48 h. In that study, 5 μM resveratrol was found to slightly prolong RLS of fibroblasts (by 2 population doublings) [44]. In a different study, 65% of resveratrol was degraded in DMEM medium after 7 days; this degradation could be prevented by the addition of superoxide dismutase and pyruvate to the culture medium. In that study, resveratrol, as well as oxyresveratrol (a naturally occurring resveratrol analog present in mulberry Morus alba L. and acetyl resveratrol (another naturally occurring resveratrol analog found in marine invertebrates), decreased RLS of human Hs68 fibroblasts at concentrations of 1-20 μM, even when these antioxidants were not degraded [46]. Other authors found that resveratrol (0.2 and 1 μM) changed the expression of 47 genes; the changes included a decrease in the level of INK4a, cyclin-dependent kinase (CDK) and α2-macroglobulin mRNA. However, the compound did not affect RLS [47]. In our experiments, resveratrol as well as curcumin (1 μM) decreased the RLS of H8F2p 25LM fibroblasts (unpublished).

Flavonoids are a large group of natural antioxidants, ubiquitously present in plants. They are present in fruits, vegetables, nuts, and plant-derived beverages such as tea and wine. Quercetin is the main flavonol present in our diet. It is the aglycon form of a number of other flavonol glycosides such as rutin (quercetin-3-O-rutinoside) and quercitrin (quercetin 3-O-a-L-rhamnoside). It is the most active flavonoid with the highest reported antioxidant activity and multiple mechanisms of antioxidant action. Quercetin caprylate (concentration not specified but ≤5 μg/ml) was found to increase the RLS of human foreskin fibroblasts (HFF1); this increase was less than 5%, but statistically significant. Quercetin and quercetin caprylate maintained young morphology of fibroblasts, delayed the appearance of senescent phenotype, increased their growth rate, and had a morphologically rejuvenating effect on terminally senescent fibroblasts. They also activated proteasomes, and this effect was suggested to be the main one responsible for the antiaging effect of these compounds on the fibroblasts [48]. Recent studies evidenced that quercetin and caffeic acid in old fibroblasts induced higher expression of aging counteracting genes compared to resveratrol; caffeic acid increased sirtuin 6 (SIRT6) gene expression, and quercetin increased sirtuin 1 (SIRT1) gene expression, thus inducing an antiaging effect. Moreover, quercetin as well as caffeic acid induced higher expression of SIRT1 and Nuclear Receptor Subfamily 1, Group D, Member 1 (NR1D1) genes than resveratrol in fibroblasts [49].

Epigallocatechin gallate (EGCG) is the most active and major polyphenol in green tea and is well known to be a primary contributor to the potential benefits of green and black tea to human health [50, 51]. EGCG has a very similar structure to that of resveratrol, including hydroxyls in the two metapositions of the A ring, trans to the B-ring with a 4 or 3,4-hydroxyl pattern [52]. EGCG was reported to increase the activity of antioxidant enzymes, including superoxide dismutases and catalase, and decreased the ROS level in replicatively advanced fibroblasts although its effect on their RLS was not reported [53].

Other flavonoids, anthocyanidins, were demonstrated to be effective in prolonging the RLS of fibroblasts in vitro. Cyanidin (concentration not specified) prolonged the RLS of normal human diploid fibroblasts (WI-38) by 4 PD (from 64 to 68) when added at passage 26, by 3 PD when added at passage 42, and by 1 PD when added at passage 58 [54]. Malvidin, one of the most abundant polyphenol components of black rice and red wines, had a similar effect. When added at passage 26, malvidin prolonged RLS from 64 to 67 PD; when added at passage 42, it prolonged RLS from 42 to 46 PD; and when added at 58 PD, it prolonged RLS of WI-38 fibroblasts from 62 to 63 PD. Unfortunately, malvidin concentration was also not specified [55].

Liu et al. indicated that urolithin A, a product of ellagitannin degradation by gut bacteria, significantly increased the expression of type I collagen and reduced the expression of matrix metalloproteinase 1 (MMP-1) in senescent human dermal fibroblasts. What is more, urolithin A decreased intracellular ROS, which can be partially due to the activation of the Nrf2-mediated antioxidant response. Urolithin A (50 μM) caused changes in cell morphology and inhibited cell proliferation, due to cell cycle arrest in the G2/M phase. Nevertheless, SA-β-gal staining and γH2AX immunofluorescence staining showed that cellular senescence status of the fibroblasts did not change [56].

18α-Glycyrrhetinic acid (enoxolone), a pentacyclic triterpenoid derived from the hydrolysis of glycyrrhizic acid, was obtained from the herb liquorice Glycyrrhiza glabra. It is used in flavoring, and it masks the bitter taste of drugs like aloe and quinine. It is effective in the treatment of peptic ulcers and has antitussive and possibly antiviral, antifungal, antiprotozoal, and antibacterial activities. This compound, present in the culture of lung fibroblasts, increased their RLS from 58.5 to 64.3 PD. It decreased ROS production, but its main effect is supposed to be stimulation of the synthesis of proteasome subunits mediated by nuclear erythroid factor 2 (Nrf2). Knockdown of Nrf2 by siRNA decreased the RLS of fibroblasts (from 44.7 down to 42.5 PD) [57].

Berberine, an isoquinoline alkaloid compound, which is extracted from numerous herbs across the globe, has a long history of medicinal use in China as well as in traditional Ayurvedic medicine. Berberine improved the morphology and induced rejuvenation of replicatively advanced human lung fibroblasts, as judged from senescence markers including SA-β-gal. Berberine promoted the entry of cell cycles from the G0 or G1 phase to S/G2-M phase thus improving cell growth and proliferation. Enhanced proliferation of 2BS (PD45) and WI38 (PD45) cells was observed during seven days of incubation. Only 3.5% SA-β-gal-positive 2BS cells were seen in the treated PD30 cells, while 60% were observed in late PDL cells. In berberine-treated 2BS cells (PD45), the SA-β-gal-positive cell rate reverted to the level of young cells (16%), as compared to the control group (56.5%). The level of p16 decreased and that of cyclin protein and cyclin-dependent kinases, such as cyclin D1 and CDK4, increased. The level of phosphorylated retinoblastoma protein (pRB) was upregulated [58].

Betel vine (Piper betle Linn. (PB)) extract, a traditional medicine that is widely used to treat different diseases in Asia, modulated the expression of senescence-associated genes of senescent human fibroblasts. Piper betle extracts at 0.4 mg/ml could improve cell proliferation of young, presenescent, and senescent fibroblasts by 143%, 127%, and 157%, respectively. Increased expressions of PRDX6, TP53, CDKN2A, PAK2, and mitogen-activated protein kinase 14 (MAPK14) were observed in senescent fibroblasts compared to young and presenescent cells. Treatment with the extracts modulated the transcriptional profile changes in senescent HDFs. Expression of Cu,Zn-superoxide dismutase (SOD1) gene increased, whereas those of GPX1, PRDX6, TP53, CDKN2A, PAK2, and MAPK14 decreased in senescent treated with the extract compared to untreated senescent fibroblasts [59].

Ginsenoside Rg3, enriched from steamed or heated ginseng roots, exerts multiple pharmacological effects showing anticancer, antiangiogenic, and antidiabetic activities [60]. It was found that Rg3(S) reverses the replicative senescence of fibroblasts by modulating Akt-mTOR-sirtuin signaling to promote the biogenesis of mitochondria. Ginsenoside stereoisomer Rg3(S) (10 and 30 μM) decreased SA-β-gal staining and restored the decreased ATP level, the decreased NAD+/NADH ratio, and the increased ROS level in senescent fibroblasts. Rg3(S) downregulated phosphatidylinositol 3-kinase/Akt through the inhibition of mTOR by cell cycle regulators like p53/p21 in senescent HDFs, whereas the stereoisomer Rg3(R) did not alter the corresponding signaling pathways. Rg3(S) stimulated mitochondrial biogenesis via activation of sirtuin 3/PGC1α [61].

Expression of senescence-associated genes related to antioxidants and DNA damage-associated signaling, insulin/insulin-like growth factor-1 signaling, cell differentiation, and cell proliferation pathways was modulated by Chlorella vulgaris extract in the course of replicative senescence of human fibroblasts. Treatment of young HDFs with Chlorella vulgaris extract decreased the expression of SOD1, catalase (CAT), and copper chaperone for superoxide dismutase (CCS) genes and increased the expression of the SOD2 gene. Treatment of senescent fibroblasts with C. vulgaris extract downregulated also the expression of genes for the p53 protein and cyclin-dependent kinase inhibitor 2A and upregulated the expression of MAPK14 gene in presenescent and senescent fibroblasts [62].

Kinetin, a synthetic cytokinin plant hormone, which has some senescence-retarding effects in plants and acts as an indirect antioxidant, stimulated antioxidant defense not only in plants [63] but also in animal cells, including fibroblasts [64]. Kinetin (40-200 μM) treatment of cultured fibroblasts did not have any significant effect on RLS, although the cells retained some characteristic features of young cells like a lower level of fluorescence due to accumulation of lipofuscin, lack of highly polymerized and rod-like actin filaments, and lack of multiple and disorganized microtubular network [65].

The dipeptide carnosine (β-alanyl-L-histidine) is an antioxidant and compound preventing nonenzymatic protein glycosylation (glycation), present in muscle cells at a concentration of ca 20 mM. Its effect on fibroblast aging and RLS was thus tested at high concentrations (20-50 mM). 20 mM carnosine added starting from passage 9 extended the RLS of human foreskin HFF1 fibroblasts by 7.4 and 9.4 PD, while 30 mM carnosine present from passage 13 extended it by 3.0 and 6.3 PD; 50 mM carnosine added at passage 10 did not prolong RLS although it extended chronologic lifespan (from 432 to 716 days). In human fetal lung fibroblast cells (MRC-5), 20 mM carnosine present from passage 14 extended RLS by 10 and 14 PD in independent experiments, while 30 mM carnosine present from passage 14 extended RLS by 4 to 8 PD. Interestingly, the transfer of MRC-5 fibroblasts at 55 PD, which already showed characteristic signs of senescence, to a medium containing 20 mM or 30 mM carnosine, induced a remarkable morphological rejuvenation and RLS prolongation, by 13.0 and 12.1 PD, respectively. The effect of L-carnosine on cell morphology is much stronger in DMEM medium than in MEM medium. D-Carnosine (20 mM) did not increase the RLS of HFF1 fibroblasts, in contrast to L-carnosine, although the antioxidant properties of both forms of carnosine did not differ. This suggests that RLS prolongation by L-carnosine is due to some features of this compound other than its antioxidant action [66]. Hipkiss and Brownson proposed that carnosine may react with protein carbonyl groups to produce protein-carbonyl-carnosine adducts (“carnosinylated” proteins). The authors suggested that these proposals can help explain the antiaging actions of carnosine and its presence in nonmitotic cells of long-lived mammals [67]. Furthermore, Shao et al. showed that human diploid fetal lung fibroblasts grown in 20 mM carnosine exhibited a slower telomere shortening rate and extended lifespan measured in population doublings. It seems that the reduction in telomere shortening rate and damages in telomeric DNA made a significant contribution to the antiaging effect of carnosine [68].

Nicotinamide, a precursor of the coenzyme NAD+, serves to rapidly synthesize NAD+ through the salvage pathway once taken up by cells. It inhibits sirtuin activity. It has been shown to positively affect cell survival in a variety of cell types. It also enhances an adaptive response to physical and chemical damage, protects brain cells from oxidative damage caused by reperfusion after ischemic infarction, and prevents injury of pancreatic islet cells during free radical exposure. Moreover, it was reported to protect against mitochondrial damage [26]. Nicotinamide (0.5 and 5 mM) slightly increased RLS of human diploid foreskin fibroblasts (FB0603) (from 23 to 25 PD) [47]. In another study, 3 mM nicotinamide was found to induce transient and reversible morphological rejuvenation of aged IMR-90 fibroblasts. Nicotinamide increased the activity of histone acetyltransferase and attenuated the fibroblast-aging related changes in the expression of the gene coding for PI3K IIb (a subtype of the PI3K family lipid/protein kinases) [12]. Kang et al. found a significant effect of 5 mM nicotinamide, dependent on the duration of treatment. Nicotinamide was introduced at PD 30. When the compound was withdrawn at PD 90 from cells grown in high glucose (25 mM), the cells proliferated for 21-more doublings and senesced at PD 111, while when nicotinamide was removed at PD 74, they proliferated until PD 93. The cells cultured in the normal glucose medium (5.5 mM glucose) proliferated significantly further after the removal of nicotinamide (cells senesced at PD 121, when removed at PD 100, and at PD 110 when removed at PD 86). Apparently, cell proliferation stopped at 20 or so PDs after the removal of nicotinamide. The cells that were cultured in the high-glucose medium proliferated until PD 109 when fed nicotinamide starting from PD 52, while those fed starting from PD 70 proliferated only to PD 79. Therefore, the earlier the cells were treated with nicotinamide, the more the lifespan was extended. For the cells cultured in normal level glucose, longer-term nicotinamide treatment was necessary to be effective as delayed treatment showed no effect. The authors argued that these results indicate that lifespan extension was induced not by nicotinamide itself but by certain changes caused by nicotinamide and the effect of this change lasted for a substantial number of population doublings [26]. Kwak et al. found that 5 mM nicotinamide prolonged the RLS of human foreskin fibroblasts, decreased appearance of SA-β-gal activity, lipofuscin accumulation, and mitochondrial superoxide level [69].

A procedure simulating calorie restriction, viz. culturing fibroblasts in a medium of lowered glucose concentration, was found to increase RLS of human fibroblasts. This effect has been ascribed to an increase in the activity of nicotinamide phosphoribosyltransferase, elevation in the intracellular NAD+ level, and activation of sirtuin1 activity [70].

α-Phenyl-t-butyl nitrone (PBN), which can act as an antioxidant, increased dose dependently the RLS of the human diploid fibroblast strain IMR-90, in the concentration range of 100-800 μM. α-Phenyl-t-butyl nitrone was most effective, when added to cells just before they reduced their growth rate. The treatment of replicatively young cells with PBN caused a small inhibition of cell growth. An optimal effect (increase in RLS by 7.1 PD) was observed when PBN was added at 42.2 PD; addition at 21.1 PD increased RLS only by 0.9 PD [22]. N-t-butyl hydroxylamine, a product of PBN decomposition, prolonged the RLS of IMR-90 by 19.7 PD at 100 μM. Another product of PBN decomposition, benzaldehyde, was without effect or toxic at high concentrations. Other hydroxylamines, N-benzyl hydroxylamine and N-methyl hydroxylamine, delayed the senescence of IMR-90 cells by at least 17–20 PD. A simultaneous treatment of the cells with all three N-hydroxylamines (30 μM each) yielded results similar to single treatments, delaying senescence by 14–17 PD. In contrast, the isomeric O-hydroxylamines at concentrations equivalent to the N-hydroxylamines either were without effect (O-t-butyl hydroxylamine) or induced a small decline in the final number of PDs (O-benzyl hydroxylamine and O-methyl hydroxylamine) [30].

Although nicotinamide and N-t-butyl hydroxylamine caused a similar level of lifespan extension in human fibroblasts, their action mechanisms may not be the same. The magnitude of the effect of nicotinamide was dependent on the duration of the treatment, and even after nicotinamide was removed, the population doubling continued for a further 20 or so PDs. In the case of N-t-butyl hydroxylamine, the magnitude of the effect was not dependent on treatment duration, nor was it cumulative. The lifespan gains were more prominent when they were applied to cells close to senescence. The effect of nicotinamide is also different from that of carnosine [66] and other antioxidant chemicals. Although carnosine had a pronounced effect in preventing senescent morphology, cells quickly entered senescence state upon its removal, neither did its effect appear to be cumulative. These differences suggest that the effect of nicotinamide is not a direct antioxidant effect [26].

Methylene Blue (MB) is a diaminophenothiazine that has been in clinical use for approximately 100 years in the treatment of a variety of ailments. Methylene Blue treats congenital and poison-induced methemoglobinemia, prevents the side effects of chemotherapy, and treats septic shock. There is weak evidence that chronic MB administration (2.5 mg/kg/day) extends the lifespan of mice. Methylene Blue was found to extend RLS of IRC-90 fibroblasts by >20 PD, 100 nM MB being more effective than 10 nM and 1 μM stain. Interestingly, under 5% oxygen, 1 μM MB was nearly as efficient as the 100 nM MB. Methylene Blue delayed cell senescence when administered at any PDL; however, the efficiency decreased as the starting PDL increased. The effect of MB was enhanced by simultaneous addition of 10 μM or 100 μM N-t-butyl hydroxylamine (increase of RLS by 30 PD; 100 nM alone: 21.5 PD). Thionine delayed cell senescence, though at higher concentrations than MB (1 μM). Compounds with chemical structures similar to MB: 1,9-dimethyl-MB, Toluidine Blue O, and Celestin Blue were without effect. Methylene Blue increased the rate of cellular respiration, but this effect was indirect, mediated by changes in cellular metabolism. Dose dependently, MB induced or inhibited biosynthesis of Complex IV, heme synthesis and iron uptake, and increased ROS production measured with DCFDA [71]. Methylene Blue enhanced also fibroblast growth and induced Nrf2 and its downstream the antioxidant response element- (ARE-) response genes [72].

Fibroblasts used in studies of the effects of antioxidants on the RLS are listed in Table 1, and a summary of the results obtained is shown in Table 2.


FibroblastsOriginReferences

2BSHuman fetal lung diploid fibroblasts human, female[58]
FB0603Human diploid foreskin fibroblasts[47]
H8F2p 25LM fibroblastsIsolated from human ear[73]
HDFsHuman dermal fibroblasts[8, 56, 6062, 74]
HE49Human embryonic fibroblasts, normal[37]
HEFsHuman embryonic fibroblasts, established from an abortus[35]
HFF1 (ATCC® SCRC1041™)Human foreskin, from a newborn male[48, 66]
HFL1 (ATCC® CCL-153™)Isolated from human fetal lungs, Caucasian[57]
HGPSNormal human skin fibroblast[72]
Hs68 (ATCC® CRL-1635™)Human skin (foreskin), from a newborn male, Caucasian[46]
IMR-90 (ATCC® CCL-186™)Human lung, female, 16 weeks of gestation, Caucasian[12, 22, 30, 71]
MRC-5 (ATCC® CCL-171™)Human lung, 14 weeks of gestation fetus, male, Caucasian[44, 66, 75]
Normal diploid fibroblastsIsolated from foreskin[25, 26, 59]
Normal human skin fibroblasts[64]
NYaKeNormal human adult fibroblasts derived from a 23-year-old healthy male[27]
Primary cultures of human dermal fibroblastsFemale[65]
WI-38 (ATCC® CCL-75™)Human fetal lung diploid fibroblasts, 3 months of gestation fetus, female, Caucasian[33, 34, 54, 55, 58, 76]
WS3RGBFibroblasts obtained from a 42-year-old female Werner syndrome patient[37]


AntioxidantCell line; concentration; effect on RLSOther effectsReference

1,9-Dimethyl-Methylene Blue, Toluidine Blue O, and Celestin BlueIMR-90 fibroblasts; concentration not specified: no effect[71]
18α-Glycyrrhetinic acidHFL1 fibroblasts; 2 μg/ml; increase in RLS (58.5 to 64.3 PD)Decrease in ROS level, Nrf2-mediated proteasome activation[57]
2,2,6,6-Tetramethylpiperidine-1-oxyl (TEMPO)IMR-90 fibroblasts; 25 μM: no effect; 100 μM: decrease of RLS (8–9PD)[30]
3,3,5,5-Tetramethyl-l-pyrroline N-oxideIMR-90 fibroblasts; 500 μM; slight increase in RLS (+1 PD)[22]
3-Carbamoyl-2,2,5,5-tetramethylpyrrolidin-1-yloxy (3-CP)IMR-90 fibroblasts; 25 μM; no effect; 100 μM: decrease of RLS (8–9PD)[30]
4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (4-OH-TEMPO)IMR-90 fibroblasts; 25 μM: no effect; 100 μM: decrease of RLS (8–9PD)[30]
Ascorbic acid 2-phosphate200 μM: HE49 cells, increase in RLS by 8.5 PD (20%) and 7.1 PD (2% O2); NYaKe cells, increase in RLS by 3.5 PD; WS3RGB cells, increase in RLS by 5.5 PDReduction of the rate of telomere shortening; decreased ROS level under 20% oxygen but not under 2% oxygen[37]
BenzaldehydeIMR-90 fibroblasts; 100 μM: no or toxic effect[30]
Berberine2BS and WI38 fibroblasts; 0.3125 μg/ml: no effect on RLS reportedEnhanced proliferation of cells during seven days of incubation. 3.5% SA-β-gal-positive cells seen in PD30 2BS cells, vs. 60% in late PDL cells; in berberine-treated 2BS cells (PD45), the SA-β-gal-positive cell rate reverted to 16%, as compared to the control group (56.5%).
Decreased level of p16; cyclin protein and cyclin-dependent kinases, such as cyclin D1 and CDK4 increased. Upregulated level of phosphorylated retinoblastoma protein (pRB)
[58]
Butylated hydroxytolueneIMR-90 fibroblasts; 100 μM: no increase of RLS[22]
CarnosineHFF1 cells; 20 mM: RLS increased by 7.4 and 9.4 PD; 30 mM: RLS increased by 3.0, 4.3 and 6.3 PD; 50 mM: RLS decreased.
MRC-5 cells; 20 mM: RLS extension by 10 and 14 PD; 30 mM: RLS extension by 4 and 8 PD; 20 mM and 30 mM, introduced at 55 PD: RLS increase by 13.0 and 12.1 PD, respectively.
HFF-1 cells; 20 mM D-carnosine: no effect
50 mM carnosine: more flat, spread-out appearance; maintaining nonsenescent morphology[66]
Chlorella vulgaris extractHuman diploid fibroblasts (HDFs); no effect of RLS reportedYoung HDFs: reduced expression of SOD1, CAT, and CCS. Senescent cells: increased expression of the SOD2 and MAPK14 genes, downregulation of TP53 gene expression. Young and senescent HDFs: decreased expression of CDKN2A gene, increased expression of MAPK14 gene[62]
CurcuminH8F2p 25LM fibroblasts; 1: decrease of RLSSadowska-Bartosz et al., unpublished
CyanidinWI-38 cells; concentration not specified: increase of RLS (from 64 to 68 when added at 26 PD, from 62 to 65 when added at 42 PD, and from 62 to 63 when added at 58 PD)[54]
Epigallocatechin gallateHuman diploid fibroblasts (HDF); 12.5 μM: effect on RLS not reportedDecrease of ROS level, increased mitochondrial potential, more intact mitochondrial DNA, elevated activities of antioxidative enzymes, more juvenile cell status[53]
Ginsenoside Rg3(S)HDFs maintained until different passages: PD 8-12 (young cells) and PD 34-36 (senescent cells). Senescent HDFs starved with serum-free DMEM overnight and then incubated in DMEM containing 10 or 30 μM Rg3(S) or (R) for 48 h: no effect on RLS reportedDecrease in percentages of SA-β-gal staining cells in replicatively old HDFs. Reversal of the replicative senescence of HDFs: restoration of the ATP level and NAD+/NADH ratio in senescent HDFs. Recovering the cellular levels of ROS and the NAD+/NADH ratio in young HDFs treated with rotenone. Downregulation of phosphatidylinositol 3-kinase/Akt through the inhibition of mTOR by cell cycle regulators like p53/p21 in senescent HDFs. Activation of sirtuin 3/PGC1α to stimulate mitochondrial biogenesis. Rg3(R) did not alter the corresponding signaling pathways[61]
KinetinPrimary cultures of human dermal fibroblasts; 40-200 μM: no effect on RLSCells retained some characteristic features of young cells[65]
L-SulforaphaneIMR-90 fibroblasts; 1 nM–10 μM: no effect[71]
MalvidinWI-38 cells; concentration not specified: increase of RLS (from 64 to 67 when added at 26 PD, from 62 to 66 when added at 42 PD, and from 62 to 63 when added at 58 PD)[55]
Methylene BlueIMR-90 fibroblasts; 100 nM: extension of RLS by >20 PDIncrease in ROS generation; concentration-dependent changes in the synthesis of complex IV and heme and iron uptake[71]
N,N-Diphenyl-1,4-phenylenediamineIMR-90 fibroblasts; 40 μM: no increase of RLS[21]
N-AcetylcysteineIMR-90 fibroblasts; 2 mM: no increase of RLS[22]
N-Benzyl hydroxylamineIMR-90 fibroblasts; 100 μM: RLS prolongation by at least 17–20 PDDecrease in Rh123 accumulation, prevention of the age-dependent decline in the activity of aconitase[30]
NicotinamideFB0603 fibroblasts; 0.5 and 5 mM: small increase in RLS (+2 PD)[47]
NicotinamideIMR-90 fibroblasts; 3 mM: no significant effect atMorphological rejuvenation of aged cells[12]
NicotinamideNHFs; 5 mM from PD 30: significant extension of RLSDecreased lipofuscin accumulation, decreased mitochondrial superoxide, decreased acidic β-galactosidase[69]
Nitroso-tert-butane (tNB)IMR-90 fibroblasts; 10 μM: no effect[30]
N-Methyl hydroxylamineIMR-90 fibroblasts; 100 μM: RLS prolongation by at least 17–20 PDDecrease in Rh123 accumulation, prevention of the age-dependent decline in the activity of aconitase[30]
N-t-Butyl hydroxylamineIMR-90 fibroblasts; 10 μM: RLS prolongation by 5.8 PD; 100 μM: RLS prolongation by 19.7Decrease in Rh123 accumulation, prevention of the age-dependent decline in the activity of aconitase[30]
O-Benzyl hydroxylamineIMR-90 fibroblasts; 100 μM: small decrease in RLS[30]
O-Methyl hydroxylamineIMR-90 fibroblasts; small decrease in RLS at 100 μM[30]
O-t-Butyl hydroxylamineIMR-90 fibroblasts; 100 μM: no effect[30]
Piper betle (PB)Primary HDFs derived from foreskins of three different male subjects aged between 9 and 12 years after circumcision; 0.4 mg/ml: no effect on RLS reportedImprovement of cell proliferation of young (143%), presenescent (127.3%) and senescent (157.3%) HDFs. Increased expressions of PRDX6, TP53, CDKN2A, PAK2, and MAPK14 in senescent HDFs. Modulation of the transcriptional profile changes in senescent HDFs. Increased expressions of SOD1, decreased expression of GPX1, PRDX6, TP53, CDKN2A, PAK2, and MAPK14 in PB-treated senescent HDFs[59]
Quercetin caprylate, conc.HFL1 fibroblasts; concentration not specified (≤5 μg/ml): a statistically significant increase in RLS, less than 5%Maintenance of young morphology, delay in appearance of senescent phenotype, increase in growth rate; proteasome activation; morphological rejuvenation[48]
ResveratrolMRC-5 cells; 5 μM: small increase in RLS (+2 PD)Reduced DNA breaks, attenuation of age-related increase in nuclear size, reduction in the level of acetylated forms of H3 and H4 histones and p53[44]
ResveratrolFB0603 cells; 0.2 and 1 μM: no effect on RLS[47]
ResveratrolH8F2p 25LM fibroblasts; 1 μM: decrease of RLSSadowska-Bartosz et al., unpublished
Resveratrol, oxyresveratrol, acetyl-resveratrolHs68 cells; 1-20 μM resveratrol, oxy-resveratrol, acetyl-resveratrol: decrease in RLS[46]
Salicylic acidIMR-90 fibroblasts; 200 μM: no increase of RLS[22]
ThionineIMR-90 fibroblasts; 1 μM: extension of RLS[71]
Urolithin AHuman dermal fibroblasts; no effect of RLS reportedSignificantly increased type I collagen expression and reduced matrix metalloproteinase 1 (MMP-1) expression; reduced intracellular ROS, partially due to activation of the Nrf2-mediated antioxidative response. 50 μM: changes in cell morphology and inhibition in cell proliferation, due to cell cycle arrest in G2/M phase. SA-β-gal and γH2AX unaltered[56]
Vitamin C (ascorbic acid)HEFs; extension of RLS by 2 PD (2 μM), 6 PD (20 μM), and 11 PD (200)Decreased SA-β-gal staining, decreased ROS level, increase in aconitase activity, decrease in of p53, phospho-p53 at Ser15and p21 and apurinic/apyrimidinic site level, relieve of senescence-related G1 arrest[35]
Vitamin EWI-38 cells; 10 μg/ml and 100 μg/ml: increase in RLS (from 65 to 109 and 115, resp.)Size and shape typical of replicatively young cells, decreased autofluorescence[33]
Vitamin EWI-38 cells; 10 μg/ml, 50 μg/ml and 100 μg/ml: no effect on RLS[34]
α-Phenyl-t-butyl nitrone (PBN)IMR-90 fibroblasts; 200 μM: increase in RLS from PD to PD[22]
α-Phenyl-t-butyl nitrone (PBN)IMR-90 fibroblasts; 200 μM: RLS prolongation by 2.4 PD; 800 μM: RLS prolongation by 14.8 PD[30]
α-Tocopherol acetateIMR-90 fibroblasts; 200 μM: no increase of RLS[22]

4. Is the Action of Antioxidants due to Their Antioxidant Activity?

Compounds known as antioxidants have usually other physiological effects, indirectly related or not related at all to their antioxidant properties [77, 78]. Therefore, it should be taken into account that the effects of antioxidants on the RLS of fibroblasts may be due not (only) to their direct antioxidant actions but to their other biological activities.

Activation of sirtuins extends the lifespan and promotes longevity and healthy aging. Sirtuins are a family of NAD+-dependent enzymes that deacetylate substrates ranging from histones to transcriptional regulators, and they have been implicated in the molecular mechanisms of aging. It has also been reported that inhibitors of histone deacetylases accelerate cellular senescence [8]. Histone deacetylases are involved in DNA methylation and chromatin remodeling and thus in the modulation of gene expression [79]. SIRT-1, the mammalian ortholog of the yeast Sir2 protein, regulates, by means of deacetylation, the activity of proteins that play a crucial role in cellular senescence, such as p53 and the Forkhead Box O (FOXO) transcription factors [80, 81]. It was reported that the level of SIRT-1 decreases with serial cell passages as cells approach senescence [82]. Resveratrol was shown to be a sirtuin activator acting as an antiaging molecule in yeast cells [83]. This polyphenol has been shown to increase lifespan also in nematodes and fruit flies functioning as calorie restriction mimetic [84].

The proteasome is responsible for the removal of both normal and damaged proteins. Due to its latter function, the proteasome is also considered a main secondary antioxidant mechanism that becomes activated upon oxidative challenge. It is responsible for the cellular clearance from damaged and oxidized proteins that may cause deleterious side effects [8587] upon lack of proteolysis and aggregation. It has been found that fibroblast cultures undergoing replicative senescence have reduced levels of proteasome activity accompanied by lower proteasome content due to the downregulation of its β-catalytic subunit [88]. The expression of proteasome subunits and the relative proteasome activities can be modulated by exogenous stimuli. The genes responsible for the formation of the 26S proteasome complex are coordinately regulated by Nrf2 in response to antioxidants [89]. More recently, Tan et al. evidenced that platelet-derived growth factor (PDGF) signaling and cytoskeletal structure can be dysregulated in senescent HDFs. The proproliferative effect of gamma-tocotrienol on senescent HDFs may be mediated through the stimulation of cellular response to stress and carbohydrate metabolism [74].

Aging is associated with progressive and site-specific changes in DNA methylation (DNAm). Fibroblasts mirror the established DNAm topology of the age-related elongation of very long-chain fatty acid (ELOVL2) gene in human blood and the rapid hypermethylation of its promoter cg16867657, which correlates with a linear decrease in ELOVL2 mRNA levels across the lifespan. Using generalized additive modeling on twelve timepoints across the lifespan. Sturm et al. showed how single CpGs exhibit loci-specific, linear, and nonlinear trajectories that reach rates up to -47% (hypomethylation) to +23% (hypermethylation) per month. Together, these high-temporal resolution, global, gene-specific, and single CpG data highlight the conserved and accelerated nature of epigenetic aging in cultured fibroblasts, which may constitute a system to evaluate age-modifying interventions across the lifespan [90].

Fibroblast RLS was reported to be increased by cortisone [91]. While high doses of ionizing radiation are known to decrease RLS of fibroblasts, it was claimed that relatively low doses ( Gy and  Gy) “can increase lifespan” of MRC-5 fibroblasts. However, this statement in the abstract of the paper is rather weakly supported by the reported data. Two cultures were irradiated 3 times with a dose of 1 Gy; the RLS of one was 65.9 PD, which is practically the same as that of control (66.1 PD); only for the second culture, RLS was prolonged (73.3 vs. 68.1 PD). Of course, the mean of two experiments pointed to an increase in RLS, but the reproducibility of this effect is far from satisfactory. A  Gy treatment lightly increased the RLS of cells in one culture (from 66.1 to 67.0 PD), while the RLS of the second culture was decreased (from 68.1 to 63.4 PD). While these data are not too convincing, the author reported that irradiated cultures had extended chronological time and some irradiated populations continued to grow long after controls had ceased cell division. The author hypothesized that multiple doses of γ rays may lead to the emergence of transformed lines from normal diploid human fibroblasts, which may have longer RLS or even be immortal, in analogy with induction of cancer by radiation. An alternative explanation was a cell response to stress induced by ionizing radiation [75]. In this context, it should be reminded that many antioxidants are known to autoxidize in cell culture media producing hydrogen peroxide, thus exerting a prooxidant effect [9294]. It has been suggested in different contexts that the protective action of antioxidants can be partly due to their hormetic effect [95, 96]. Perhaps, a similar effect of antioxidants on the RLS of fibroblasts in vitro can be also ascribed, to some extent, to hydrogen peroxide produced by them or/and their other oxidation products.

5. Concluding Remarks

Fibroblasts are the cell type used as the first and most frequently to study aging at the cellular level in vitro. The interest in the effects of antioxidants on human lifespan and skin aging stimulated interest in studies of the effects of antioxidants on the RLS of fibroblasts in vitro.

Experiments on the in vitro effects of antioxidants may have limited relevance to the in vivo situation where high concentrations of antioxidants are usually not attainable and antioxidants are not so prone to autooxidation due to the lower oxygen concentration and more reducing environment. However, experiments on fibroblasts are more relevant to the applications of antioxidants in cosmetics as the exposure of antioxidants on or in the skin to oxygen may be comparable to that under conditions of in vitro cell culture, so the results of in vitro experiments on fibroblasts aging may be of relevance for the design of skin protecting preparations.

Evident from the presented data is the poor reproducibility of results between laboratories, and sometimes even within a lab. In spite of high standardization of cell culture methods, there are some factors, which evade scrutinous control, one of them concerning the way of preparation of antioxidant solutions and the time of their existence in the culture medium. It may be one of the factors contributing to the variability of results.

While some studies failed to demonstrate any positive effects of the RLS of fibroblasts, most studies pointed to small effects (increase by several PD) and few reported a significant prolongation of RLS. Further studies are needed to confirm the results of the most effective antioxidants and provide a deeper insight into the mechanisms of their action.

Abbreviations

BMEM:Basal Modified Eagle’s Medium
DCFDA:2,7-Dichlorofluorescin diacetate
DMEM:Dulbecco’s Modified Eagle Medium
ECM:Extracellular matrix
EGCG:Epigallocatechin gallate
HDAC:Histone deacetylase
HSFs:Human skin fibroblasts
MEM:Eagle Minimal Essential Medium
N-HDAC:Nicotinamide adenine dinucleotide- (NAD+-) dependent histone deacetylase
PD:Population doubling
Rh123:Rhodamine 123
RLS:Replicative lifespan
ROS:Reactive oxygen species
SA-β-gal:Senescence-associated β-galactosidase
SIRT:Sirtuin
SOD:Superoxide dismutase
TEMPO:2,2,6,6-Tetramethylpiperidine-1-oxyl
TEMPOL:4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl.

Data Availability

Data are available on request. Please contact I. Sadowska-Bartosz (e-mail: isadowska@poczta.fm).

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

I.S.-B. and G.B. were responsible for the concept of the article, literature review, and preparation of the manuscript.

Acknowledgments

This study was performed within the project “Modification of cellular aging in vitro by inhibitors of non-enzymatic protein modifications” (number of application 2015/17/B/NZ3/03731) financed by National Science Centre in Poland in a program “OPUS 9.”

References

  1. V. Zorin, A. Zorina, N. Smetanina et al., “Diffuse colonies of human skin fibroblasts in relation to cellular senescence and proliferation,” Aging, vol. 9, no. 5, pp. 1404–1413, 2017. View at: Publisher Site | Google Scholar
  2. A. Carrell, “On the permanent life of tissues outside of the organism,” Journal of Experimental Medicine, vol. 15, no. 5, pp. 516–528, 1912. View at: Publisher Site | Google Scholar
  3. L. Hayflick and P. S. Moorhead, “The serial cultivation of human diploid cell strains,” Experimental Cell Research, vol. 25, no. 3, pp. 585–621, 1961. View at: Publisher Site | Google Scholar
  4. L. Hayflick, “The limited in vitro lifetime of human diploid cell strains,” Experimental Cell Research, vol. 37, no. 3, pp. 614–636, 1965. View at: Publisher Site | Google Scholar
  5. J. Campisi, “Cellular senescence as a tumor-suppressor mechanism,” Trends in Cell Biology, vol. 11, no. 11, pp. S27–S31, 2001. View at: Publisher Site | Google Scholar
  6. R. D. Ramirez, C. P. Morales, B. S. Herbert et al., “Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions,” Genes & Development, vol. 15, no. 4, pp. 398–403, 2001. View at: Publisher Site | Google Scholar
  7. S. Marthandan, S. Priebe, P. Hemmerich, K. Klement, and S. Diekmann, “Long-term quiescent fibroblast cells transit into senescence,” PLoS One, vol. 9, no. 12, article e115597, 2014. View at: Publisher Site | Google Scholar
  8. V. V. Ogryzko, T. H. Hirai, V. R. Russanova, D. A. Barbie, and B. H. Howard, “Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent,” Molecular and Cellular Biology, vol. 16, no. 9, pp. 5210–5218, 1996. View at: Publisher Site | Google Scholar
  9. G. Saretzki, N. Sitte, U. Merkel, R. E. Wurm, and T. von Zglinicki, “Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments,” Oncogene, vol. 18, no. 37, pp. 5148–5158, 1999. View at: Publisher Site | Google Scholar
  10. A. G. Bodnar, M. Ouellette, M. Frolkis et al., “Extension of life-span by introduction of telomerase into normal human cells,” Science, vol. 279, no. 5349, pp. 349–352, 1998. View at: Publisher Site | Google Scholar
  11. P. M. Reaper, F. D. di Fagagna, and S. P. Jackson, “Activation of the DNA damage response by telomere attrition: a passage to cellular senescence,” Cell Cycle, vol. 3, no. 5, pp. 543–546, 2004. View at: Google Scholar
  12. K. Matuoka, K. Y. Chen, and T. Takenawa, “Rapid reversion of aging phenotypes by nicotinamide through possible modulation of histone acetylation,” Cellular and Molecular Life Sciences, vol. 58, no. 14, pp. 2108–2116, 2001. View at: Publisher Site | Google Scholar
  13. S. Imai, C. M. Armstrong, M. Kaeberlein, and L. Guarente, “Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase,” Nature, vol. 403, no. 6771, pp. 795–800, 2000. View at: Publisher Site | Google Scholar
  14. R. Holliday, L. I. Huschtscha, G. M. Tarrant, and T. B. Kirkwood, “Testing the commitment theory of cellular aging,” Science, vol. 198, no. 4315, pp. 366–372, 1977. View at: Publisher Site | Google Scholar
  15. R. Holliday, L. I. Huschtscha, and T. B. Kirkwood, “Cellular aging: further evidence for the commitment theory,” Science, vol. 213, no. 4515, pp. 1505–1508, 1981. View at: Publisher Site | Google Scholar
  16. E. Hara, H. Tsurui, A. Shinozaki, S. Nakada, and K. Oda, “Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1,” Biochemical and Biophysical Research Communications, vol. 179, no. 1, pp. 528–534, 1991. View at: Publisher Site | Google Scholar
  17. V. J. Cristofalo and R. J. Pignolo, “Replicative senescence of human fibroblast-like cells in culture,” Physiological Reviews, vol. 73, no. 3, pp. 617–638, 1993. View at: Publisher Site | Google Scholar
  18. A. Macieira-Coelho, “Chromatin reorganization during senescence of proliferating cells,” Mutation Research, vol. 256, no. 2-6, pp. 81–104, 1991. View at: Publisher Site | Google Scholar
  19. K. H. Walen, “Human diploid fibroblast cells in senescence; cycling through polyploidy to mitotic cells,” In Vitro Cellular & Developmental Biology–Animal, vol. 42, no. 7, pp. 216–224, 2006. View at: Publisher Site | Google Scholar
  20. Q. M. Chen, J. Liu, and J. B. Merrett, “Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts,” Biochemical Journal, vol. 347, no. 2, pp. 543–551, 2000. View at: Publisher Site | Google Scholar
  21. A. Mocali, L. Giovannelli, P. Dolara, and F. Paoletti, “The comet assay approach to senescent human diploid fibroblasts identifies different phenotypes and clarifies relationships among nuclear size, DNA content, and DNA damage,” Journals of Gerontology Series A-Biological Sciences and Medical Sciences, vol. 60, no. 6, pp. 695–701, 2005. View at: Publisher Site | Google Scholar
  22. Q. Chen, A. Fischer, J. D. Reagan, L. J. Yan, and B. N. Ames, “Oxidative DNA damage and senescence of human diploid fibroblast cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 10, pp. 4337–4341, 1995. View at: Publisher Site | Google Scholar
  23. G. P. Dimri, X. Lee, G. Basile et al., “A biomarker that identifies senescent human cells in culture and in aging skin in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9363–9367, 1995. View at: Publisher Site | Google Scholar
  24. G. H. Stein and V. Dulic, “Origins of G1 arrest in senescent human fibroblasts,” BioEssays, vol. 17, no. 6, pp. 537–543, 1995. View at: Publisher Site | Google Scholar
  25. E. Hütter, H. Unterluggauer, F. Uberall, H. Schramek, and P. Jansen-Dürr, “Replicative senescence of human fibroblasts: the role of Ras-dependent signaling and oxidative stress,” Experimental Gerontology, vol. 37, no. 10-11, pp. 1165–1174, 2002. View at: Publisher Site | Google Scholar
  26. H. T. Kang, H. I. Lee, and E. S. Hwang, “Nicotinamide extends replicative lifespan of human cells,” Aging Cell, vol. 5, no. 5, pp. 423–436, 2006. View at: Publisher Site | Google Scholar
  27. D. A. Alcorta, Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J. C. Barrett, “Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 24, pp. 13742–13747, 1996. View at: Publisher Site | Google Scholar
  28. T. Giordano, D. Kleinsek, and D. N. Foster, “Increase in abundance of a transcript hybridizing to elongation factor I alpha during cellular senescence and quiescence,” Experimental Gerontology, vol. 24, no. 5-6, pp. 501–513, 1989. View at: Publisher Site | Google Scholar
  29. M. Martin, R. El Nabout, C. Lafuma, F. Crechet, and J. Remy, “Fibronectin and collagen gene expression during in vitro ageing of pig skin fibroblasts,” Experimental Cell Research, vol. 191, no. 1, pp. 8–13, 1990. View at: Publisher Site | Google Scholar
  30. H. Atamna, A. Paler-Martínez, and B. N. Ames, “N-t-Butyl hydroxylamine, a hydrolysis product of α-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts,” Journal of Biological Chemistry, vol. 275, no. 10, pp. 6741–6748, 2000. View at: Publisher Site | Google Scholar
  31. T. Jung, A. Höhn, B. Catalgol, and T. Grune, “Age-related differences in oxidative protein-damage in young and senescent fibroblasts,” Archives of Biochemistry and Biophysics, vol. 483, no. 1, pp. 127–135, 2009. View at: Publisher Site | Google Scholar
  32. L. Packer and K. Fuehr, “Low oxygen concentration extends the lifespan of cultured human diploid cells,” Nature, vol. 267, no. 5610, pp. 423–425, 1977. View at: Publisher Site | Google Scholar
  33. L. Packer and J. R. Smith, “Extension of the lifespan of cultured normal human diploid cells by vitamin E,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 12, pp. 4763–4767, 1974. View at: Publisher Site | Google Scholar
  34. L. Packer and J. R. Smith, “Extension of the lifespan of cultured normal human diploid cells by vitamin E: a reevaluation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 4, pp. 1640-1641, 1977. View at: Publisher Site | Google Scholar
  35. W. S. Hwang, S. H. Park, H. S. Kim et al., “Ascorbic acid extends replicative life span of human embryonic fibroblast by reducing DNA and mitochondrial damages,” Nutrition Research and Practice, vol. 1, no. 2, pp. 105–112, 2007. View at: Publisher Site | Google Scholar
  36. T. Kanatate, N. Nagao, M. Sugimoto, K. Kageyama, T. Fujimoto, and N. Miwa, “Differential susceptibility of epidermal keratinocytes and neuroblastoma cells to cytotoxicity of ultraviolet-B light irradiation prevented by the oxygen radical-scavenger ascorbate-2-phosphate but not by ascorbate,” Cellular & Molecular Biology Research, vol. 41, no. 6, pp. 561–567, 1995. View at: Google Scholar
  37. G. Kashino, S. Kodama, Y. Nakayama et al., “Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells,” Free Radical Biology & Medicine, vol. 35, no. 4, pp. 438–443, 2003. View at: Publisher Site | Google Scholar
  38. D. K. Ingram, M. Zhu, J. Mamczarz et al., “Calorie restriction mimetics: an emerging research field,” Aging Cell, vol. 5, no. 2, pp. 97–108, 2006. View at: Publisher Site | Google Scholar
  39. Y. Hu, J. Liu, J. Wang, and Q. Liu, “The controversial links among calorie restriction, SIRT1, and resveratrol,” Free Radical Biology & Medicine, vol. 51, no. 2, pp. 250–256, 2011. View at: Publisher Site | Google Scholar
  40. Z. H. Mnjoyan and K. Fujise, “Profound negative regulatory effects by resveratrol on vascular smooth muscle cells: a role of p53–p21WAF1/CIP1 pathway,” Biochemical and Biophysical Research Communications, vol. 311, no. 2, pp. 546–552, 2003. View at: Publisher Site | Google Scholar
  41. E. H. Heiss, Y. D. C. Schilder, and V. M. Dirsch, “Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells,” Journal of Biological Chemistry, vol. 282, no. 37, pp. 26759–26766, 2007. View at: Publisher Site | Google Scholar
  42. T. Walle, F. Hsieh, M. H. DeLegge, J. E. Oatis Jr., and U. K. Walle, “High absorption but very low bioavailability of oral resveratrol in humans,” Drug Metabolism & Disposition, vol. 32, no. 12, pp. 1377–1382, 2004. View at: Publisher Site | Google Scholar
  43. L. Kuršvietienė, I. Stanevičienė, A. Mongirdienė, and J. Bernatonienė, “Multiplicity of effects and health benefits of resveratrol,” Medicina, vol. 52, no. 3, pp. 148–155, 2016. View at: Publisher Site | Google Scholar
  44. L. Giovannelli, V. Pitozzi, M. Jacomelli et al., “Protective effects of resveratrol against senescence-associated changes in cultured human fibroblasts,” Journals of Gerontology Series A-Biological Sciences and Medical Sciences, vol. 66, no. 1, pp. 9–18, 2011. View at: Publisher Site | Google Scholar
  45. N. C. Yang, C. H. Lee, and T. Y. Song, “Evaluation of resveratrol Oxidationin Vitroand the crucial role of bicarbonate ions,” Bioscience, Biotechnology, and Biochemistry, vol. 74, no. 1, pp. 63–68, 2014. View at: Publisher Site | Google Scholar
  46. Y. J. Chang, Y. C. Chang, R. H. Liu, C. W. Chen, I. Lee, and N. C. Yang, “Resveratrol can be stable in a medium containing fetal bovine serum with pyruvate but shortens the lifespan of human fibroblastic Hs68 cells,” Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 2371734, 15 pages, 2018. View at: Publisher Site | Google Scholar
  47. M. Stefani, M. A. Markus, R. C. Lin, M. Pinese, I. W. Dawes, and B. J. Morris, “The effect of resveratrol on a cell model of human aging,” Annals of the New York Academy of Sciences, vol. 1114, no. 1, pp. 407–418, 2007. View at: Publisher Site | Google Scholar
  48. N. Chondrogianni, S. Kapeta, I. Chinou, K. Vassilatou, I. Papassideri, and E. S. Gonos, “Anti-ageing and rejuvenating effects of quercetin,” Experimental Gerontology, vol. 45, no. 10, pp. 763–771, 2010. View at: Publisher Site | Google Scholar
  49. Y. Okada and M. Okada, “Quercetin, caffeic acid and resveratrol regulate circadian clock genes and aging-related genes in young and old human lung fibroblast cells,” Molecular Biology Reports, vol. 47, no. 2, pp. 1021–1032, 2020. View at: Publisher Site | Google Scholar
  50. J. C. Mak, “Potential role of green tea catechins in various disease therapies: progress and promise,” Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 3, pp. 265–273, 2012. View at: Publisher Site | Google Scholar
  51. K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270–278, 2009. View at: Publisher Site | Google Scholar
  52. D. W. Han, M. H. Lee, B. Kim, J. J. Lee, S. H. Hyon, and J. C. Park, “Preventive effects of epigallocatechin-3-O-gallate against replicative senescence associated with p53 acetylation in human dermal fibroblasts,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 850684, 13 pages, 2012. View at: Publisher Site | Google Scholar
  53. Q. Meng, C. N. Velalar, and R. Ruan, “Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast,” Free Radical Biology & Medicine, vol. 44, no. 6, pp. 1032–1041, 2008. View at: Publisher Site | Google Scholar
  54. M. J. Choi, B. K. Kim, K. Y. Park, T. Yokozawa, Y. O. Song, and E. J. Cho, “Anti-aging effects of cyanidin under a stress-induced premature senescence cellular system,” Biological and Pharmaceutical Bulletin, vol. 33, no. 3, pp. 421–426, 2010. View at: Publisher Site | Google Scholar
  55. H. R. Seo, M. J. Choi, J. M. Choi, J. C. Ko, J. Y. Ko, and E. J. Cho, “Malvidin protects WI-38 human fibroblast cells against stress-induced premature senescence,” Journal of Cancer Prevention, vol. 21, no. 1, pp. 32–40, 2016. View at: Publisher Site | Google Scholar
  56. C. F. Liu, X. L. Li, Z. L. Zhang et al., “Antiaging effects of urolithin a on replicative senescent human skin fibroblasts,” Rejuvenation Research, vol. 22, no. 3, pp. 191–200, 2019. View at: Publisher Site | Google Scholar
  57. S. Kapeta, N. Chondrogianni, and E. S. Gonos, “Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts,” Journal of Biological Chemistry, vol. 285, no. 11, pp. 8171–8184, 2010. View at: Publisher Site | Google Scholar
  58. Y. Dang, Y. An, J. He et al., “Berberine ameliorates cellular senescence and extends the lifespan of mice via regulating p16 and cyclin protein expression,” Aging Cell, vol. 19, no. 1, article e13060, 2020. View at: Publisher Site | Google Scholar
  59. L. W. Durani, S. C. Khor, J. K. Tan, K. H. Chua, Y. A. Mohd Yusof, and S. Makpol, “Piper betle L. modulates senescence-associated genes expression in replicative senescent human diploid fibroblasts,” Biomedical Research International, vol. 2017, article 6894026, pp. 1–9, 2017. View at: Publisher Site | Google Scholar
  60. P. Mohanan, S. Subramaniyam, R. Mathiyalagan, and D. C. Yang, “Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions,” Journal of Ginseng Research, vol. 42, no. 2, pp. 123–132, 2018. View at: Publisher Site | Google Scholar
  61. K. E. Yang, H. J. Jang, I. H. Hwang et al., “Stereoisomer-specific ginsenoside 20(S)-Rg3 reverses replicative senescence of human diploid fibroblasts via Akt-mTOR-Sirtuin signaling,” Journal of Ginseng Research, vol. 44, no. 2, pp. 341–349, 2020. View at: Publisher Site | Google Scholar
  62. F. Jaafar, L. W. Duran, and S. Makpol, “Chlorella vulgaris modulates the expression of senescence-associated genes in replicative senescence of human diploid fibroblasts,” Molecular Biology Reports, vol. 47, no. 1, pp. 369–379, 2020. View at: Publisher Site | Google Scholar
  63. M. A. Ahanger, M. N. Alyemeni, L. Wijaya et al., “Potential of exogenously sourced kinetin in protecting Solanum lycopersicum from NaCl-induced oxidative stress through up-regulation of the antioxidant system, ascorbate-glutathione cycle and glyoxalase system,” PLoS One, vol. 13, no. 9, article e0202175, 2018. View at: Publisher Site | Google Scholar
  64. A. Jabłońska-Trypuć, M. Matejczyk, and R. Czerpak, “N6-benzyladenine and kinetin influence antioxidative stress parameters in human skin fibroblasts,” Molecular and Cellular Biochemistry, vol. 413, no. 1-2, pp. 97–107, 2016. View at: Publisher Site | Google Scholar
  65. S. I. Rattan and B. F. Clark, “Kinetin delays the onset of ageing characteristics in human fibroblasts,” Biochemical and Biophysical Research Communications, vol. 201, no. 2, pp. 665–672, 1994. View at: Publisher Site | Google Scholar
  66. G. A. McFarland and R. Holliday, “Retardation of the senescence of cultured human diploid fibroblasts by carnosine,” Experimental Cell Research, vol. 212, no. 2, pp. 167–175, 1994. View at: Publisher Site | Google Scholar
  67. A. R. Hipkiss and C. Brownson, “A possible new role for the anti-ageing peptide carnosine,” Cellular and Molecular Life Sciences, vol. 57, no. 5, pp. 747–753, 2000. View at: Publisher Site | Google Scholar
  68. L. Shao, Q. H. Li, and Z. Tan, “L-Carnosine reduces telomere damage and shortening rate in cultured normal fibroblasts,” Biochemical and Biophysical Research Communications, vol. 324, no. 2, pp. 931–936, 2004. View at: Publisher Site | Google Scholar
  69. J. Y. Kwak, H. J. Ham, C. M. Kim, and E. S. Hwang, “Nicotinamide exerts antioxidative effects on senescent cells,” Molecules and Cells, vol. 38, no. 3, pp. 229–235, 2015. View at: Publisher Site | Google Scholar
  70. N. C. Yang, T. Y. Song, Y. Z. Chang, M. Y. Chen, and M. L. Hu, “Up-regulation of nicotinamide phosphoribosyltransferase and increase of NAD+ levels by glucose restriction extend replicative lifespan of human fibroblast Hs68 cells,” Biogerontology, vol. 16, no. 1, pp. 31–42, 2015. View at: Publisher Site | Google Scholar
  71. H. Atamna, A. Nguyen, C. Schultz et al., “Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways,” FASEB Journal, vol. 22, no. 3, pp. 703–712, 2008. View at: Publisher Site | Google Scholar
  72. Z. M. Xiong, M. O'Donovan, L. Sun, J. Y. Choi, M. Ren, and K. Cao, “Anti-aging potentials of methylene blue for human skin longevity,” Scientific Reports, vol. 7, no. 1, article 2475, 2017. View at: Publisher Site | Google Scholar
  73. N. Pieńkowska, G. Bartosz, M. Pichla, M. Grzesik-Pietrasiewicz, M. Gruchala, and I. Sadowska-Bartosz, “Effect of antioxidants on the H2O2-induced premature senescence of human fibroblasts,” Aging, vol. 12, no. 2, pp. 1910–1927, 2020. View at: Publisher Site | Google Scholar
  74. J. K. Tan, F. Jaafar, and S. Makpol, “Proteomic profiling of senescent human diploid fibroblasts treated with gamma-tocotrienol,” BMC Complementary and Alternative Medicine, vol. 18, no. 1, p. 314, 2018. View at: Publisher Site | Google Scholar
  75. R. Holliday, “A re-examination of the effects of ionizing radiation on lifespan and transformation of human diploid fibroblasts,” Mutation Research, vol. 256, no. 2-6, pp. 295–302, 1991. View at: Publisher Site | Google Scholar
  76. G. Hammad, Y. Legrain, Z. Touat-Hamici et al., “Interplay between selenium levels and replicative senescence in WI-38 human fibroblasts: a proteomic approach,” Antioxidants, vol. 7, no. 1, article e19, 2018. View at: Publisher Site | Google Scholar
  77. L. O. Klotz and H. Steinbrenner, “Cellular adaptation to xenobiotics: interplay between xenosensors, reactive oxygen species and FOXO transcription factors,” Redox Biology, vol. 13, pp. 646–654, 2017. View at: Publisher Site | Google Scholar
  78. K. Pallauf, N. Duckstein, M. Hasler, L. O. Klotz, and G. Rimbach, “Flavonoids as putative inducers of the transcription factors Nrf2, FoxO, and PPARγ,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 4397340, 11 pages, 2017. View at: Publisher Site | Google Scholar
  79. S. Eden, T. Hashimshony, I. Keshet, H. Cedar, and A. W. Thorne, “DNA methylation models histone acetylation,” Nature, vol. 394, no. 6696, p. 842, 1998. View at: Publisher Site | Google Scholar
  80. H. Vaziri, S. K. Dessain, E. Ng Eaton et al., “hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase,” Cell, vol. 107, no. 2, pp. 149–159, 2001. View at: Publisher Site | Google Scholar
  81. Y. Kobayashi, Y. Furukawa-Hibi, C. Chen et al., “SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress,” International Journal of Molecular Medicine, vol. 16, no. 2, pp. 237–243, 2005. View at: Google Scholar
  82. T. Sasaki, B. Maier, A. Bartke, and H. Scrable, “Progressive loss of SIRT1 with cell cycle withdrawal,” Aging Cell, vol. 5, no. 5, pp. 413–422, 2006. View at: Publisher Site | Google Scholar
  83. K. T. Howitz, K. J. Bitterman, H. Y. Cohen et al., “Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan,” Nature, vol. 425, no. 6954, pp. 191–196, 2003. View at: Publisher Site | Google Scholar
  84. J. G. Wood, B. Rogina, S. Lavu et al., “Sirtuin activators mimic caloric restriction and delay ageing in metazoans,” Nature, vol. 430, no. 7000, pp. 686–689, 2004. View at: Publisher Site | Google Scholar
  85. K. J. Davies, “Intracellular proteolytic systems may function as secondary antioxidant defenses: an hypothesis,” Journal of Free Radical Biology & Medicine, vol. 2, no. 3, pp. 155–173, 1986. View at: Publisher Site | Google Scholar
  86. T. Grune, T. Reinheckel, and K. J. A. Davies, “Degradation of oxidized proteins in mammalian cells,” FASEB Journal, vol. 11, no. 7, pp. 526–534, 1997. View at: Publisher Site | Google Scholar
  87. B. Friguet, A. L. Bulteau, N. Chondrogianni, M. Conconi, and I. Petropoulos, “Protein degradation by the proteasome and its implications in aging,” Annals of the New York Academy of Sciences, vol. 908, pp. 143–154, 2000. View at: Publisher Site | Google Scholar
  88. N. Chondrogianni, I. P. Trougakos, D. Kletsas, Q. M. Chen, and E. S. Gonos, “Partial proteasome inhibition in human fibroblasts triggers accelerated M1 senescence or M2 crisis depending on p53 and Rb status,” Aging Cell, vol. 7, no. 5, pp. 717–732, 2008. View at: Publisher Site | Google Scholar
  89. M. K. Kwak, N. Wakabayashi, J. L. Greenlaw, M. Yamamoto, and T. W. Kensler, “Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway,” Molecular and Cellular Biology, vol. 23, no. 23, pp. 8786–8794, 2003. View at: Publisher Site | Google Scholar
  90. G. Sturm, A. Cardenas, M. A. Bind et al., “Human aging DNA methylation signatures are conserved but accelerated in cultured fibroblasts,” Epigenetics, vol. 14, no. 10, pp. 961–976, 2019. View at: Publisher Site | Google Scholar
  91. A. Macieira-Coelho, “Action of cortisone on human fibroblasts in vitro,” Experientia, vol. 22, no. 6, pp. 390-391, 1966. View at: Publisher Site | Google Scholar
  92. B. Halliwell, “Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?” Archives of Biochemistry and Biophysics, vol. 476, no. 2, pp. 107–112, 2008. View at: Publisher Site | Google Scholar
  93. H. Arakawa, M. Maeda, S. Okubo, and T. Shimamura, “Role of hydrogen peroxide in bactericidal action of catechin,” Biological and Pharmaceutical Bulletin, vol. 27, no. 3, pp. 277–281, 2004. View at: Publisher Site | Google Scholar
  94. M. Grzesik, G. Bartosz, I. Stefaniuk, M. Pichla, J. Namieśnik, and I. Sadowska-Bartosz, “Dietary antioxidants as a source of hydrogen peroxide,” Food Chemistry, vol. 278, pp. 692–699, 2019. View at: Publisher Site | Google Scholar
  95. S. I. S. Rattan, “Biogerontology: research status, challenges and opportunities,” Acta BioMedica, vol. 89, no. 2, pp. 291–301, 2018. View at: Publisher Site | Google Scholar
  96. R. Franco, G. Navarro, and E. Martínez-Pinilla, “Hormetic and mitochondria-related mechanisms of antioxidant action of phytochemicals,” Antioxidants, vol. 8, no. 9, p. 373, 2019. View at: Publisher Site | Google Scholar

Copyright © 2020 Izabela Sadowska-Bartosz and Grzegorz Bartosz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views546
Downloads250
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.